BidaskClub upgraded shares of NantHealth (NASDAQ:NH) from a sell rating to a hold rating in a report released on Tuesday morning.
A number of other research analysts have also issued reports on the company. Zacks Investment Research lowered NantHealth from a buy rating to a hold rating in a research report on Tuesday, January 9th. Canaccord Genuity decreased their target price on NantHealth from $6.00 to $5.00 and set a buy rating on the stock in a research report on Friday, November 17th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of Buy and a consensus price target of $8.05.
Shares of NantHealth (NASDAQ:NH) opened at $3.67 on Tuesday. The company has a debt-to-equity ratio of 0.93, a current ratio of 2.38 and a quick ratio of 2.36. NantHealth has a 52-week low of $2.60 and a 52-week high of $6.43. The company has a market capitalization of $402.99, a P/E ratio of -2.06 and a beta of 0.64.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Advisor Group Inc. acquired a new stake in shares of NantHealth in the 4th quarter worth $450,000. Millennium Management LLC acquired a new stake in shares of NantHealth in the 4th quarter worth $344,000. Dimensional Fund Advisors LP acquired a new stake in shares of NantHealth in the 3rd quarter worth $365,000. Northern Trust Corp increased its stake in shares of NantHealth by 133.9% in the 2nd quarter. Northern Trust Corp now owns 151,907 shares of the company’s stock worth $643,000 after acquiring an additional 86,955 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in shares of NantHealth by 91.5% in the 2nd quarter. Goldman Sachs Group Inc. now owns 169,603 shares of the company’s stock worth $717,000 after acquiring an additional 81,024 shares during the last quarter. 6.27% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “NantHealth (NH) Upgraded by BidaskClub to Hold” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3252339/nanthealth-nh-upgraded-by-bidaskclub-to-hold.html.
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.